Gunderson Dettmer has advised Headline as lead investor on the transaction. Blossom Health, a provider of an AI-powered operating system for psychiatry, has completed a Series...
Blossom Health Raises $20 Million in Series A Funding Led by Headline
Galadyne Secures $4.8 Million Pre-Seed Funding for Missile Platform Development
Gunderson Dettmer has advised Galadyne on the deal. Galadyne has completed a $4.8 million pre-seed financing round to support its mission of redefining missile architecture for...
CertifID Secures $47.5 Million in Series C Financing
Gunderson Dettmer has advised CertifID. CertifID, an Austin-based company specializing in wire fraud prevention for real estate transactions, has secured $47.5 million in a Series C...
OpenAI Startup Fund and Thrive Global’s Launch of Thrive AI Health
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Thrive AI Health in the transaction. The OpenAI Startup Fund and Thrive Global announced the launch of a...
Bite’s $9 Million Series A Funding Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Bite in the transaction. Bite raised $9 million in a Series A funding round led by Staley Capital. The round included participation...
Solu Therapeutics’ $31 Million Seed Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Solu Therapeutics in the transaction. Solu Therapeutics announced the closing of an oversubscribed $31 million seed financing co-led...